Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History
Status:
Completed
Trial end date:
2018-04-10
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in
symptomatic patients with moderate to very severe COPD who are receiving standard of care
therapies